Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!

Learn More
Reporter Cell Line Construction Services for Brain Tumors
Solutions
Online Inquiry

Reporter Cell Line Construction Services for Brain Tumors

Reporter Cell Line Construction Services for Brain Tumors

Reporter cell lines are those stably expressed cell lines tagged with a reporter gene that can be used to visualize, track and isolate the target gene. Reporter cell lines can be generated by exogenous expression driven by the target gene's promoter with an easily detectable tag. However, since the level of exogenous expression may have unpredictable effects on experimental results, researchers prefer an endogenous expression of reporter genes. Reporter cell lines have been widely used in the study of gene expression regulation, signal transduction pathways, and receptor-ligand interactions to track intracellular signaling.

We offer reporter gene functional cell line construction services for brain tumors

In vitro bioactivity assays are a critical part of antibody drug development. Alfa Cytology offers a stable and affordable tool for brain tumor antibody drug development. We can customize the development of reporter gene functional cell lines to meet customer needs. It can eliminate the need for primary cell culture and overcome the limitations of traditional methods and is suitable for large-scale high-throughput brain tumor antibody drug screening, bioactivity assay, and stability determination.

The general process

Reporter cell line construction services flow - Alfa Cytology

Technical advantages

  • Vector design and construction. Surface receptor/antigen codon optimization, cis-reaction for specific targets, component optimization.
  • Assay method optimization. Most complete optimization strategy, optimal potency to target ratio, serum concentration adjustment, target cell inoculation density, and cell incubation time.
  • Stability evaluation. Target gene expression stability and functional stability.

Reporter gene functional cell lines we have successfully constructed

Immune checkpoint inhibitor Combination bioassays Fc receptor bioassay
CD47-SIRPa blockade bioassay
TIGIT/CD155 blockade bioassay
LAG3/MHCII blockade bioassay
PD-1/PD-L1 blockade bioassay
PD-1+TIGIT
CD3+CD19
CD3 Bispecific antibody series
CD16 Bispecific antibody series
ADCC reporter bioassay
ADCP reporter bioassay
Immune checkpoint activation Cytokine and signaling pathway reporter gene series
GITR activation bioassay
4-1BB activation bioassay
OX-40 activation bioassay
CD27 activation bioassay
CD40 activation bioassay

NFAT reporter cell line
NF-KB reporter cell line
NF-KB/AP-1 reporter cell line
IL-2 promoter reporter cell line
STAT-5 reporter cell line
VEGF reporter cell line
ANG2 reporter cell line

Delivery of results

  • Monoclonal functionally stable cells: target and effector cells.
  • Experimental methods: including cell culture methods and optimized in vitro protocols.
  • Mycoplasma assay reports.

Applications

  • Studying the transcriptional activity of gene promoters. For protein blotting, protein isolation and purification, affinity chromatography, immunocytochemistry, and flow cytometry
  • Protein expression, localization, and translocation in cells. Fluorescence can be used to continuously monitor the expression levels of endogenous and recombinant proteins.
  • Target identification and evaluation of drug candidates. This can be used for brain tumor drug target identification and candidate evaluation.

Alfa Cytology provides services for the construction of reporter gene functional cell lines for brain tumors, which can be applied to promoter activity studies, transcription factor studies, mammalian cell two-hybrid assays, and live animal imaging experiments. Our experts will save you time and effort and ensure the smooth running of your experiments. Please feel free to contact to communicate project details.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.